Muscular dystrophies are a group of diseases that are caused by a genetic mutation (a change in genetic material that can be passed on to children), affect muscles, and are progressive (increase in severity over time). The most common types are
Duchenne muscular dystrophy , the most common childhood form of muscular dystrophy. It is an X-linked disease, which means that the gene is passed from mothers to their sons.
Becker muscular dystrophy, with a genetic defect very similar to that in Duchenne muscular dystrophy, but not as severe. Together, Duchenne and Becker muscular dystrophies affect 1 to 2 in 10 000 males between the ages of 5 and 24 years.
Myotonic dystrophy . Patients have myotonia (delayed relaxation of muscles after contraction), for example, after grasping a doorknob. There are several different types within this group. They occur in both men and women and affect about 1 in 8000 people. The December 14, 2011, issue of JAMA includes an article about myotonic muscular dystrophy.
Grahic Jump Location
The physical examination and personal history for each type of muscular dystrophy is different and contributes to the diagnosis.
In Duchenne muscular dystrophy, young boys start walking very late and have difficulties arising from the floor (Gowers sign, using their hands to push on their legs to get up). Intellectual impairment may also be present.
In Becker muscular dystrophy, weakness may be limited to the quadriceps (muscles in the front of the thigh).
Infants with type 1 myotonic dystrophy can have severe trouble breathing and swallowing and may not survive the neonatal (newborn) period. Adults with type 1 myotonic dystrophy may develop cataracts, hand and lower leg weakness and wasting (loss of muscle mass), and grip myotonia. Adults with later-onset type 2 myotonic dystrophy can have stiffness and myotonia in the thighs and hands, neck weakness, and hip weakness with trouble climbing stairs.
The blood level of creatine kinase (a protein released with muscle breakdown) is abnormally high early in Duchenne muscular dystrophy. As the disease progresses and muscle mass decreases, the level of creatine kinase decreases.
Blood tests look for the genetic mutations that cause each type of muscular dystrophy. These allow a definitive diagnosis.
Muscular dystrophies are progressive diseases. Children with Duchenne muscular dystrophy often require a wheelchair by their teenage years, as do children with Becker muscular dystrophy in their late adolescence.
Because muscular dystrophies affect muscles everywhere in the body, including the lungs and heart, patients may need specialized care, such as a pacemaker. Each of the forms has unique features that require attention. For example, myotonic dystrophy can lead to impotence and high cholesterol levels.
Corticosteroids may improve muscle strength and function in Duchenne dystrophy. In patients with myotonic dystrophy, other medications improve myotonia. However, muscular dystrophies cannot be cured and weakness is progressive. Many people with either Duchenne or Becker muscular dystrophy may die in their early to late 20s.
Mayo Clinic www.mayoclinic.com/health/muscular-dystrophy/DS00200
Genetics Home Reference ghr.nlm.nih.gov/condition/myotonic-dystrophyghr.nlm.nih.gov/condition/duchenne-and-becker-muscular-dystrophy
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at www.jama.com. Many are available in English and in Spanish.
Sources: Mayo Clinic, Genetics Home Reference, Centers for Disease Control and Prevention
Topic: MUSCULOSKELETAL SYNDROMES
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 312/464-0776.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.